Jiangsu CoWin Biotech Co., Ltd.

SHSE:688426 Stock Report

Market Cap: CN¥2.4b

Jiangsu CoWin Biotech Balance Sheet Health

Financial Health criteria checks 6/6

Jiangsu CoWin Biotech has a total shareholder equity of CN¥1.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.7B and CN¥120.9M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥653.34m
EquityCN¥1.55b
Total liabilitiesCN¥120.91m
Total assetsCN¥1.67b

Recent financial health updates

No updates

Recent updates

Jiangsu CoWin Biotech Co., Ltd.'s (SHSE:688426) Shares Climb 30% But Its Business Is Yet to Catch Up

Mar 07
Jiangsu CoWin Biotech Co., Ltd.'s (SHSE:688426) Shares Climb 30% But Its Business Is Yet to Catch Up

Financial Position Analysis

Short Term Liabilities: 688426's short term assets (CN¥895.4M) exceed its short term liabilities (CN¥62.8M).

Long Term Liabilities: 688426's short term assets (CN¥895.4M) exceed its long term liabilities (CN¥58.1M).


Debt to Equity History and Analysis

Debt Level: 688426 is debt free.

Reducing Debt: 688426 had no debt 5 years ago.

Debt Coverage: 688426 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 688426 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies